Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
SEC Accession No. 0001193805-21-001544
Filing Date
2021-11-09
Accepted
2021-11-09 16:02:00
Documents
7
Effectiveness Date
2021-11-09

Document Format Files

Seq Description Document Type Size
1 e621051_f6ef-autolus.htm F-6EF 55924
2 e621051_ex99-a.htm EX-99.(A) 448382
3 e621051_ex99-b.htm EX-99.(B) 46981
4 e621051_ex99-d.htm EX-99.(D) 5802
5 e621051_ex99-e.htm EX-99.(E) 3716
6 GRAPHIC logo.jpg GRAPHIC 19379
7 GRAPHIC logo2.jpg GRAPHIC 5052
  Complete submission text file 0001193805-21-001544.txt   596354
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6EF | Act: 33 | File No.: 333-260904 | Film No.: 211391948
SIC: 2836 Biological Products, (No Diagnostic Substances)